Research
Hormonal
Novel incretin-based therapies have gained popularity due to their effectiveness in achieving substantial weight loss.
Healthcare providers should consider incretin-based therapies as effective options for weight management.
StrongSupportsmedium confidence
Recently, novel incretin-based therapies targeting glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors have gained popularity because of their effectiveness in achieving substantial weight loss in patients both with and without diabetes.
Why this rating
The claim is supported by multiple successful clinical trials.
Source
Contemporary Management of Obesity: A Comparison of Bariatric Metabolic Surgery and Novel Incretin Mimetic Drugs
Abhayjit Singh et al. · Diabetes Technology & Therapeutics · 2024
reviewCited 9×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →